Language Select


Advanced Search
  • Jun 7, 1999
    World’s leading software for planning prostate cancer treatments with brachytherapy "seeds" complements Varian Medical System’s cancer treatment products and services

    Palo Alto, Calif. - June 7, 1999 - Varian Medical Systems, Inc. (NYSE: VAR) today announced it has acquired the assets of the Therapy Planning Systems (TPS) Division of Multimedia Medical Systems,...

  • May 27, 1999
    Strong growth in orders and sales reported, but decline in earnings and costs from spin-off and restructuring result in loss for Varian Medical Systems

    Palo Alto, Calif. -- May 17, 1999 -- Varian Medical Systems, Inc. today reported second quarter financial results showing strong growth in orders and sales, but a net loss after a decline in...

  • May 17, 1999
    Company will pursue amorphous silicon TFT arrays business

    Palo Alto, Calif. -- May 17, 1999 -- A consortium of companies today signed an agreement with Xerox Corp. to acquire 80 percent of dpiX, a Xerox subsidiary that produces amorphous silicon...

  • Mar 31, 1999
    Board of Directors Being Reconfigured To Serve New Entities; Second-Quarter Results Expected To Be Available In Mid-May

    PALO ALTO, Calif., -- March 31,1999 -- Varian Associates, Inc., today said that it will complete its reorganization into three independent, public companies at the end of this week with the April...

  • Mar 25, 1999

    PALO ALTO, Calif., March 25, 1999, Varian Associates, Inc., (NYSE: VAR) said that trading in its soon to be independent medical equipment business began today (March 25) on the New York Stock...

Corporate Communications Contacts
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.